These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3282127)

  • 1. CAMAL: a new prognostic marker for remission in acute nonlymphoblastic leukemia.
    Logan PM; Whitney S; Naiman S; Levy JG
    Leuk Res; 1988; 12(1):19-24. PubMed ID: 3282127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of a leukemia-associated antigen (CAMAL) in peripheral blood leucocytes of bone marrow transplant patients prior to relapse.
    Levy JG; Logan PM; Whitney S; Malcolm AJ; Naiman S; Powles R; Crawford D
    Transplantation; 1985 Aug; 40(2):167-73. PubMed ID: 3895623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of a common leukemia-associated antigen in human myelogenous leukemia using immunoperoxidase.
    Logan PM; Malcolm AJ; Levy JG
    Diagn Immunol; 1984; 2(2):86-100. PubMed ID: 6238754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of residual disease in acute leukemia using immunological markers.
    Ryan DH; van Dongen JJ
    Cancer Treat Res; 1988; 38():173-207. PubMed ID: 2908595
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of a leukemia-associated antigen (CAMAL) in four myeloid leukemia cell lines.
    Shipman RC; Levy JG
    Leuk Res; 1988; 12(7):537-43. PubMed ID: 3172816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of leukemic myelopoiesis by P30-35 CAMAL, an inhibitor of normal myelopoiesis.
    Leitch HA; Buskard N; Levy JG
    Leukemia; 1993 Sep; 7(9):1394-401. PubMed ID: 8371590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell kinetics with in vivo bromodeoxyuridine assay, proliferating cell nuclear antigen expression, and flow cytometric analysis. Prognostic significance in acute nonlymphoblastic leukemia.
    Giordano M; Danova M; Mazzini G; Gobbi P; Riccardi A
    Cancer; 1993 May; 71(9):2739-45. PubMed ID: 8096794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of an in vitro inhibitor of normal myelopoiesis using a monoclonal antibody directed to a common antigen of myelogenous leukemia (CAMAL).
    Shellard JE; Leitch HA; Logan PM; McMaster WR; Levy JG
    Exp Hematol; 1991 Feb; 19(2):136-42. PubMed ID: 1991495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemic relapse in the central nervous system after allogeneic stem cell transplantation with complete remission in the bone marrow and donor-type chimerism: report of two cases.
    Ohashi H; Kato C; Fukami S; Saito H; Hamaguchi M
    Am J Hematol; 2005 Jun; 79(2):142-6. PubMed ID: 15929112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of murine hematopoiesis by CAMAL, an inhibitor of human hematopoiesis.
    Leitch HA; Yip ST; Jamieson CH; Levy JG
    Leukemia; 1993 May; 7(5):717-24. PubMed ID: 8483324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of CAMAL-mediated alterations of normal and leukemic in vitro myelopoiesis using inhibitors of proteolytic activity.
    Leitch HA; Levy JG
    Leukemia; 1994 Apr; 8(4):605-11. PubMed ID: 8152256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
    Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoclonal antibodies ICO-11 in the prognostic evaluation of acute nonlymphoblastic leukemia].
    Tupitsyn NN; Volkova MA; Perilov AA; Artem'ev AK
    Gematol Transfuziol; 1990 Aug; 35(8):7-9. PubMed ID: 2253864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double immunoenzymatic APAAP staining for the detection of leukemia-associated immunophenotypes.
    Sucić M; Boban D; Marković-Glamocak M; Uzarević B; Zadro R; Petrovecki M; Ries S; Gjadrov K; Golemović M; Stavljenić-Rukavina A; Labar B; Batinić D
    J Hematother Stem Cell Res; 1999 Dec; 8(6):635-43. PubMed ID: 10645771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAMAL: evidence for an inhibitory role in normal granulopoiesis.
    Logan PM; Shellard J; Buskard N; Levy JG
    Exp Hematol; 1989 Dec; 17(11):1072-6. PubMed ID: 2684678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic marrow transplantation for acute nonlymphoblastic leukemia.
    Fefer A
    J Natl Cancer Inst; 1986 Jun; 76(6):1275-9. PubMed ID: 3520069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute nonlymphocytic leukemia in 171 children.
    Choi SI; Simone JV
    Med Pediatr Oncol; 1976; 2(2):119-46. PubMed ID: 785198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of functional markers in acute nonlymphoblastic leukemia.
    Han K; Kahng J; Kim M; Lim J; Kim Y; Cho B; Kim HK; Min WS; Kim CC; Lee KY; Kim BK; Kang CS
    Acta Haematol; 2000; 104(4):174-80. PubMed ID: 11279307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow transplantation in acute leukemia.
    Gorin NC
    J Natl Cancer Inst; 1986 Jun; 76(6):1281-7. PubMed ID: 2940400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated tumor cells in the bone marrow (ITC-BM) of breast cancer patients before and after anthracyclin based therapy: influenced by the HER2- and Topoisomerase IIalpha-status of the primary tumor?
    Schindlbeck C; Janni W; Shabani N; Kornmeier A; Rack B; Rjosk D; Gerber B; Braun S; Sommer H; Friese K
    J Cancer Res Clin Oncol; 2005 Aug; 131(8):539-46. PubMed ID: 15887027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.